|Articles|June 1, 2002

Botulinum toxin type A approval extends to glabellar lines

Vancouver, British Columbia-The FDA recently approved the injection of botulinum toxin type A (Botox Cosmetic, Allergan, Irvine, CA) to treat moderate to severe glabellar lines in adults under age 65.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME